Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Bronchodilator responsiveness in children with asthma is not influenced by spacer device selection.

D'Vaz N, Okitika TA, Shackleton C, Devadason SG, Hall GL.

Pediatr Pulmonol. 2019 May;54(5):531-536. doi: 10.1002/ppul.24263. Epub 2019 Feb 4.

PMID:
30719873
2.

Current options in aerosolised drug therapy for children receiving respiratory support.

Trend S, von Ungern-Sternberg BS, Devadason SG, Schultz A, Everard ML.

Anaesthesia. 2017 Nov;72(11):1388-1397. doi: 10.1111/anae.14011. Epub 2017 Sep 5. Review.

3.

Lung deposition of 99mTc-radiolabeled albuterol delivered through a pressurized metered dose inhaler and spacer with facemask or mouthpiece in children with asthma.

Ditcham W, Murdzoska J, Zhang G, Roller C, von Hollen D, Nikander K, Devadason SG.

J Aerosol Med Pulm Drug Deliv. 2014 Aug;27 Suppl 1:S63-75. doi: 10.1089/jamp.2014.1139.

PMID:
25054483
4.

The concentration of iron in real-world geogenic PM₁₀ is associated with increased inflammation and deficits in lung function in mice.

Zosky GR, Iosifidis T, Perks K, Ditcham WG, Devadason SG, Siah WS, Devine B, Maley F, Cook A.

PLoS One. 2014 Feb 28;9(2):e90609. doi: 10.1371/journal.pone.0090609. eCollection 2014.

5.

Vibrating membrane devices deliver aerosols more efficient than standard devices: a study in a neonatal upper airway model.

Tiemersma S, Minocchieri S, van Lingen RA, Nelle M, Devadason SG.

J Aerosol Med Pulm Drug Deliv. 2013 Oct;26(5):280-6. doi: 10.1089/jamp.2012.0993. Epub 2012 Dec 28.

6.

Validation of radiolabeling of drug formulations for aerosol deposition assessment of orally inhaled products.

Devadason SG, Chan HK, Haeussermann S, Kietzig C, Kuehl PJ, Newman S, Sommerer K, Taylor G.

J Aerosol Med Pulm Drug Deliv. 2012 Dec;25 Suppl 1:S6-9. doi: 10.1089/jamp.2012.1Su3.

PMID:
23215848
7.

Introduction: Aerosol delivery of orally inhaled agents.

Corcoran TE, Devadason SG, Kuehl PJ.

J Aerosol Med Pulm Drug Deliv. 2012 Dec;25 Suppl 1:S3-5. doi: 10.1089/jamp.2012.1Su2.

8.

Standardization of techniques for using planar (2D) imaging for aerosol deposition assessment of orally inhaled products.

Newman S, Bennett WD, Biddiscombe M, Devadason SG, Dolovich MB, Fleming J, Haeussermann S, Kietzig C, Kuehl PJ, Laube BL, Sommerer K, Taylor G, Usmani OS, Zeman KL.

J Aerosol Med Pulm Drug Deliv. 2012 Dec;25 Suppl 1:S10-28. doi: 10.1089/jamp.2012.1Su4.

PMID:
23215844
9.

Editorial: Standards for lung imaging techniques.

Laube BL, Corcoran TE, Devadason SG, Dolovich MB, Fleming J, Newman S.

J Aerosol Med Pulm Drug Deliv. 2012 Dec;25 Suppl 1:S1-2. doi: 10.1089/jamp.2012.1Su1. No abstract available.

PMID:
23215843
10.

Usefulness of parental response to questions about adherence to prescribed inhaled corticosteroids in young children.

Schultz A, Sly PD, Zhang G, Venter A, Devadason SG, le Souëf PN.

Arch Dis Child. 2012 Dec;97(12):1092-6. doi: 10.1136/archdischild-2012-302312. Epub 2012 Oct 25.

PMID:
23100609
11.

Incentive device improves spacer technique but not clinical outcome in preschool children with asthma.

Schultz A, Sly PD, Zhang G, Venter A, Le Souëf PN, Devadason SG.

J Paediatr Child Health. 2012 Jan;48(1):52-6. doi: 10.1111/j.1440-1754.2011.02190.x. Epub 2011 Nov 1.

12.

What the pulmonary specialist should know about the new inhalation therapies.

Laube BL, Janssens HM, de Jongh FH, Devadason SG, Dhand R, Diot P, Everard ML, Horvath I, Navalesi P, Voshaar T, Chrystyn H; European Respiratory Society; International Society for Aerosols in Medicine.

Eur Respir J. 2011 Jun;37(6):1308-31. doi: 10.1183/09031936.00166410. Epub 2011 Feb 10.

13.

Usage of spacers in respiratory laboratories and the delivered salbutamol dose of spacers available in Australia and New Zealand.

Hall GL, Annese T, Looi K, Devadason SG.

Respirology. 2011 May;16(4):639-44. doi: 10.1111/j.1440-1843.2011.01928.x.

PMID:
21261779
14.

Aerosol inhalation from spacers and valved holding chambers requires few tidal breaths for children.

Schultz A, Le Souëf TJ, Venter A, Zhang G, Devadason SG, Le Souëf PN.

Pediatrics. 2010 Dec;126(6):e1493-8. doi: 10.1542/peds.2010-1377. Epub 2010 Nov 15.

PMID:
21078734
15.

The role of GSTP1 polymorphisms and tobacco smoke exposure in children with acute asthma.

Schultz EN, Devadason SG, Khoo SK, Zhang G, Bizzintino JA, Martin AC, Goldblatt J, Laing IA, Le Souëf PN, Hayden CM.

J Asthma. 2010 Nov;47(9):1049-56. doi: 10.1080/02770903.2010.508856.

PMID:
20858151
16.

Validation of methodology for recording breathing and simulating drug delivery through spacers and valved holding chambers.

Schultz A, Le Souëf TJ, Looi K, Zhang G, Le Souëf PN, Devadason SG.

J Aerosol Med Pulm Drug Deliv. 2010 Oct;23(5):311-22. doi: 10.1089/jamp.2008.0733.

PMID:
20455768
17.

Providing feedback on adherence increases use of preventive medication by asthmatic children.

Burgess SW, Sly PD, Devadason SG.

J Asthma. 2010 Mar;47(2):198-201. doi: 10.3109/02770900903483840.

PMID:
20170329
18.

In utero smoke exposure and role of maternal and infant glutathione s-transferase genes on airway responsiveness and lung function in infancy.

Murdzoska J, Devadason SG, Khoo SK, Landau LI, Young S, Goldblatt J, Zhang G, Le Souëf PN, Hayden CM.

Am J Respir Crit Care Med. 2010 Jan 1;181(1):64-71. doi: 10.1164/rccm.200812-1887OC. Epub 2009 Oct 22.

PMID:
19850945
19.

The transient value of classifying preschool wheeze into episodic viral wheeze and multiple trigger wheeze.

Schultz A, Devadason SG, Savenije OE, Sly PD, Le Souëf PN, Brand PL.

Acta Paediatr. 2010 Jan;99(1):56-60. doi: 10.1111/j.1651-2227.2009.01508.x.

PMID:
19764920
20.

Aerosol delivery of nebulised budesonide in young children with asthma.

Schueepp KG, Devadason SG, Roller C, Minocchieri S, Moeller A, Hamacher J, Wildhaber JH.

Respir Med. 2009 Nov;103(11):1738-45. doi: 10.1016/j.rmed.2009.04.029. Epub 2009 Jun 18.

21.

Assessing adherence and factors associated with adherence in young children with asthma.

Burgess SW, Sly PD, Morawska A, Devadason SG.

Respirology. 2008 Jun;13(4):559-63. doi: 10.1111/j.1440-1843.2008.01292.x. Epub 2008 Apr 14.

PMID:
18422868
22.

Novel spacer device does not improve adherence in childhood asthma.

Burgess SW, Sly PD, Cooper DM, Devadason SG.

Pediatr Pulmonol. 2007 Aug;42(8):736-9.

PMID:
17588243
23.

Facemasks and aerosol delivery in vivo.

Erzinger S, Schueepp KG, Brooks-Wildhaber J, Devadason SG, Wildhaber JH.

J Aerosol Med. 2007;20 Suppl 1:S78-83; discussion S83-4.

PMID:
17411409
24.

Association of maternal smoking with increased infant oxidative stress at 3 months of age.

Noakes PS, Thomas R, Lane C, Mori TA, Barden AE, Devadason SG, Prescott SL.

Thorax. 2007 Aug;62(8):714-7. Epub 2007 Mar 13.

25.

The effects of maternal smoking on early mucosal immunity and sensitization at 12 months of age.

Noakes P, Taylor A, Hale J, Breckler L, Richmond P, Devadason SG, Prescott SL.

Pediatr Allergy Immunol. 2007 Mar;18(2):118-27.

PMID:
17338784
26.

In vitro validation of 99mTc-HFA-FP delivered via pMDI-spacer.

Roller CM, Schaefer NC, Zhang G, Devadason SG.

J Aerosol Med. 2006 Fall;19(3):254-60.

PMID:
17034301
27.

Spacer inhalation technique and deposition of extrafine aerosol in asthmatic children.

Roller CM, Zhang G, Troedson RG, Leach CL, Le Souëf PN, Devadason SG.

Eur Respir J. 2007 Feb;29(2):299-306. Epub 2006 Sep 27.

28.

Improved efficiency of budesonide nebulization using surface-active agents.

Bouwman AM, Heijstra MP, Schaefer NC, Duiverman EJ, Lesouëf PN, Devadason SG.

Drug Deliv. 2006 Sep-Oct;13(5):357-63.

PMID:
16877311
29.

Maternal smoking is associated with impaired neonatal toll-like-receptor-mediated immune responses.

Noakes PS, Hale J, Thomas R, Lane C, Devadason SG, Prescott SL.

Eur Respir J. 2006 Oct;28(4):721-9. Epub 2006 Jul 26.

30.

Recent advances in aerosol therapy for children with asthma.

Devadason SG.

J Aerosol Med. 2006 Spring;19(1):61-6. Review.

PMID:
16551216
31.

In vitro evaluation of an asthma dosing device: the smart-inhaler.

Burgess SW, Wilson SS, Cooper DM, Sly PD, Devadason SG.

Respir Med. 2006 May;100(5):841-5. Epub 2005 Oct 10.

32.

Funhaler spacer: improving adherence without compromising delivery.

Watt PM, Clements B, Devadason SG, Chaney GM.

Arch Dis Child. 2003 Jul;88(7):579-81.

33.

Distribution of technetium-99m-labelled QVAR delivered using an Autohaler device in children.

Devadason SG, Huang T, Walker S, Troedson R, Le Souëf PN.

Eur Respir J. 2003 Jun;21(6):1007-11.

34.

Subject discomfort associated with the histamine challenge in a population study.

Toelle BG, Li J, Dalton M, Devadason SG.

Respir Med. 2002 Dec;96(12):990-2.

35.

Lung dose of inhaled drugs in children with acute asthma.

Le Souef PN, Devadason SG.

J Aerosol Med. 2002 Fall;15(3):347-9. No abstract available.

PMID:
12396424
36.

Age-associated factors influencing the efficacy of various forms of aerosol therapy.

Devadason SG, Le Souef PN.

J Aerosol Med. 2002 Fall;15(3):343-5. Review. No abstract available.

PMID:
12396423
37.

Comparison of subjective and objective measures in recurrently wheezy infants.

Wildhaber JH, Dore ND, Devadason SG, Hall GL, Hamacher J, Arheden L, LeSouëf PN.

Respiration. 2002;69(5):397-405.

PMID:
12232446
38.

High-percentage lung delivery in children from detergent-treated spacers.

Wildhaber JH, Janssens HM, Piérart F, Dore ND, Devadason SG, LeSouëf PN.

Pediatr Pulmonol. 2000 May;29(5):389-93.

PMID:
10790251
39.
40.

Variability of aerosol delivery via spacer devices in young asthmatic children in daily life.

Janssens HM, Devadason SG, Hop WC, LeSouëf PN, De Jongste JC, Tiddens HA.

Eur Respir J. 1999 Apr;13(4):787-91.

41.

Washing plastic spacers in household detergent reduces electrostatic charge and greatly improves delivery.

Piérart F, Wildhaber JH, Vrancken I, Devadason SG, Le Souëf PN.

Eur Respir J. 1999 Mar;13(3):673-8.

42.

Lung deposition of budesonide from turbuhaler in asthmatic children.

Wildhaber JH, Devadason SG, Wilson JM, Roller C, Lagana T, Borgström L, LeSouëf PN.

Eur J Pediatr. 1998 Dec;157(12):1017-22.

PMID:
9877044
43.
44.

Salbutamol delivery from a hydrofluoroalkane pressurized metered-dose inhaler in pediatric ventilator circuits: an in vitro study.

Wildhaber JH, Hayden MJ, Dore ND, Devadason SG, LeSouëf PN.

Chest. 1998 Jan;113(1):186-91.

PMID:
9440589
45.

Urinary cotinine levels in early pregnancy.

Foundas M, Hawkrigg NC, Smith SM, Devadason SG, Le Souef PN.

Aust N Z J Obstet Gynaecol. 1997 Nov;37(4):383-6.

PMID:
9429697
46.

Comparison of drug delivery from conventional versus "Venturi" nebulizers.

Devadason SG, Everard ML, Linto JM, Le Souëf PN.

Eur Respir J. 1997 Nov;10(11):2479-83.

47.

Influence of driving pressure on raised-volume forced expiration in infants.

Hayden MJ, Sly PD, Devadason SG, Gurrin LC, Wildhaber JH, LeSouëf PN.

Am J Respir Crit Care Med. 1997 Dec;156(6):1876-83.

PMID:
9412569
48.

Lung deposition from the Turbuhaler in children with cystic fibrosis.

Devadason SG, Everard ML, MacEarlan C, Roller C, Summers QA, Swift P, Borgstrom L, Le Souëf PN.

Eur Respir J. 1997 Sep;10(9):2023-8.

49.

Methacholine responsiveness using the raised volume forced expiration technique in infants.

Hayden MJ, Devadason SG, Sly PD, Wildhaber JH, LeSouëf PN.

Am J Respir Crit Care Med. 1997 May;155(5):1670-5.

PMID:
9154874
50.

Aerosol delivery to wheezy infants: a comparison between a nebulizer and two small volume spacers.

Wildhaber JH, Devadason SG, Hayden MJ, Eber E, Summers QA, LeSouëf PN.

Pediatr Pulmonol. 1997 Mar;23(3):212-6.

PMID:
9094730

Supplemental Content

Loading ...
Support Center